Advertisement

Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report

Published:November 20, 2022DOI:https://doi.org/10.1016/j.jiac.2022.11.002

      Abstract

      Cryptococcal meningitis (CM) is a life-threatening disease that primarily affects patients with human immunodeficiency virus (HIV). Antifungal therapy with antiretroviral treatment (ART) usually leads to the clinical remission of CM; however, in some cases, these treatments exacerbate intracranial inflammation because of paradoxical inflammatory reaction or immune reconstitution inflammatory syndrome (IRIS). Here we report two CM cases that presented atypical clinical courses attributed to paradoxical inflammatory reactions.
      The first case was a 43-year-old man with headache and vertigo diagnosed with CM and HIV. The patient's CM not only was refractory to the antifungal combination therapy of liposomal amphotericin B (L-AMB) and fluconazole (FLCZ) but suddenly worsened because of a paradoxical inflammatory reaction after 18 days of treatment. He passed away from brain herniation on day 23. The second case was a 43-year-old man diagnosed with CM and HIV. After receiving antifungal therapy and ART, the patient's status was stable for more than 3 years with undetectable HIV-RNA. He suddenly presented with brain inflammation and was diagnosed with IRIS due to CM (CM-IRIS). His brain lesions were migratory and refractory to various antifungal therapies such as L-AMB, FLCZ, flucytosine, and intrathecal amphotericin B. Although the cryptococcal antigen in the patient's cerebrospinal fluid gradually diminished after continuous antifungal therapies, his cognitive function declined, and right hemiparesis persisted.
      These two cases of CM presented atypical clinical courses, presumably because of paradoxical inflammatory reactions. It should be noted that the onset of CM-IRIS may not necessarily depend on the timing of ART initiation.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection and Chemotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Park B.J.
        • Wannemuehler K.A.
        • Marston B.J.
        • Govender N.
        • Pappas P.G.
        • Chiller T.M.
        Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.
        AIDS. 2009; 23: 525-530
        • Sloan D.J.
        • Parris V.
        Cryptococcal meningitis: epidemiology and therapeutic options.
        Clin Epidemiol. 2014; 6: 169-182
        • Darras-Joly C.
        • Chevret S.
        • Wolff M.
        • Matheron S.
        • Longuet P.
        • Casalino E.
        • et al.
        Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus.
        Clin Infect Dis. 1996; 23: 369-376
        • Tanu S.
        • Mihir M.
        • Rajeev S.
        Annu A: neurological worsening during treatment of an immunocompetent adult with Cryptococcus neoformans meningitis.
        Med Mycol Case Rep. 2020; 27: 48-51
        • Muller M.
        • Wandel S.
        • Colebunders R.
        • Attia S.
        • Furrer H.
        • Egger M.
        • et al.
        Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.
        Lancet Infect Dis. 2010; 10: 251-261
        • Kathiresu R.
        • Zinat S.N.
        • Fernando M.
        Immune reconstitution inflammatory syndrome following Cryptococcal neoformans infection in an immunocompetent host: a case report and review of the literature.
        ID Cases. 2020; 19e00699
        • Nakajima H.
        • Takayama A.
        • Fujiki Y.
        • Ito T.
        • Kitaoka H.
        Refractory cryptococcus neoformans meningoencephalitis in an immunocompetent patient: paradoxical antifungal therapy-induced clinical deterioration related to an immune response to cryptococcal organisms.
        Case Rep Neurol. 2015; 7: 204-208
        • Einsiedel L.
        • Gordon D.L.
        • Dyer J.R.
        Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman.
        Clin Infect Dis. 2004; 39: e78-e82
        • Panackal A.A.
        • Wuest S.C.
        • Lin Y.C.
        • Wu T.
        • Zhang N.
        • Kosa P.
        • et al.
        Paradoxical immune responses in non-HIV cryptococcal meningitis.
        PLoS Pathog. 2015; 11e1004884
        • Beardsley J.
        • Wolbers M.
        • Kibengo F.M.
        • Ggayi A.B.
        • Kamali A.
        • Cuc N.T.
        • et al.
        Adjunctive dexamethasone in HIV-associated cryptococcal meningitis.
        N Engl J Med. 2016; 374: 542-554
        • Takahashi Y.
        • Morimoto N.
        • Takamiya M.
        • Morimoto M.
        • Mino S.
        • Kuramoto S.
        • et al.
        Successful treatment with corticosteroids for refractory deterioration of cryptococcal meningitis with an increasing cryptococcal antigen titer.
        J Clin Neurosci. 2020; 72: 455-457
        • Pyrgos V.
        • Seitz A.E.
        • Steiner C.A.
        • Prevots D.R.
        • Williamson P.R.
        Epidemiology of cryptococcal meningitis in the US: 1997-2009.
        PLoS One. 2013; 8e56269
        • Ratnam I.
        • Chiu C.
        • Kandala N.B.
        • Easterbrook P.J.
        Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort.
        Clin Infect Dis. 2006; 42: 418-427
        • Hashimoto H.
        • Hatakeyama S.
        • Yotsuyanagi H.
        Development of cryptococcal immune reconstitution inflammatory syndrome 41 months after the initiation of antiretroviral therapy in an AIDS patient.
        AIDS Res Ther. 2015; 12: 33
        • Perfect J.R.
        • Dismukes W.E.
        • Dromer F.
        • Goldman D.L.
        • Graybill J.R.
        • Hamill R.J.
        • et al.
        Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America.
        Clin Infect Dis. 2010; 50: 291-322
        • Mussini C.
        • Pezzotti P.
        • Miro J.M.
        • Martinez E.
        • de Quiros J.C.
        • Cinque P.
        • et al.
        Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
        Clin Infect Dis. 2004; 38: 565-571
        • Nakama T.
        • Yamashita S.
        • Hirahara T.
        • Okamoto S.
        • Honda S.
        • Watanabe M.
        • et al.
        Usefulness of intraventricular infusion of antifungal drugs through Ommaya reservoirs for cryptococcal meningitis treatment.
        J Neurol Sci. 2015; 358: 259-262
        • Shourian M.
        • Qureshi S.T.
        Resistance and tolerance to cryptococcal infection: an intricate balance that controls the development of disease.
        Front Immunol. 2019; 10: 66
        • Zhai B.
        • Wu C.
        • Wang L.
        • Sachs M.S.
        • Lin X.
        The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections.
        Antimicrob Agents Chemother. 2012; 56: 3758-3766
        • Rhein J.
        • Huppler Hullsiek K.
        • Tugume L.
        • Nuwagira E.
        • Mpoza E.
        • Evans E.E.
        • et al.
        Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial.
        Lancet Infect Dis. 2019; 19: 843-851
        • Boulware D.R.
        • Meya D.B.
        • Bergemann T.L.
        • Wiesner D.L.
        • Rhein J.
        • Musubire A.
        • et al.
        Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.
        PLoS Med. 2010; 7e1000384
        • Lewis R.J.
        • Angier M.K.
        • Williamson K.S.
        • Johnson R.D.
        Analysis of sertraline in postmortem fluids and tissues in 11 aviation accident victims.
        J Anal Toxicol. 2013; 37: 208-216
        • Alvarez M.
        • Casadevall A.
        Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages.
        Curr Biol. 2006; 16: 2161-2165
        • Yauch L.E.
        • Lam J.S.
        • Levitz S.M.
        Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
        PLoS Pathog. 2006; 2e120
        • Boulware D.R.
        • Meya D.B.
        • Muzoora C.
        • Rolfes M.A.
        • Huppler Hullsiek K.
        • Musubire A.
        • et al.
        Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
        N Engl J Med. 2014; 370: 2487-2498
        • Nosanchuk J.D.
        • Cleare W.
        • Franzot S.P.
        • Casadevall A.
        Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrations.
        Antimicrob Agents Chemother. 1999; 43: 233-239
        • Haddow L.J.
        • Colebunders R.
        • Meintjes G.
        • Lawn S.D.
        • Elliott J.H.
        • Manabe Y.C.
        • et al.
        Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions.
        Lancet Infect Dis. 2010; 10: 791-802
        • Chang C.C.
        • Dorasamy A.A.
        • Gosnell B.I.
        • Elliott J.H.
        • Spelman T.
        • Omarjee S.
        • et al.
        Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.
        AIDS. 2013; 27: 2089-2099